Dr. Evans is Professor in the Gene Expression Laboratory and March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute for Biological Studies in La Jolla, California. Dr. Evans is an authority on hormones, both their normal activities and their roles in disease. A major achievement in Evans’ lab was the discovery of a large family of receptors that respond to various steroids, vitamins A and D, and thyroid hormones. Molecular and genetic analysis of the nuclear hormone receptor family carried out in the Evans lab has also uncovered the molecular mechanism for receptor-regulated gene expression, leading to the identification of several novel enzyme cofactors, including histone deacetylases, histone acetyltransferases, and methyltransferases. Dr. Evans is a member of the Institute of Medicine, the National Academy of Sciences, and the American Academy of Arts and Sciences. He is an investigator of the Howard Hughes Medical Institute and winner of the 2004 Albert Lasker Award for Basic Medical Research. In addition to Syndax Pharmaceuticals, Dr. Evans has been a cofounder of several companies, including Ligand Pharmaceuticals, X-Ceptor, and Xenopharm, while serving on the scientific advisory board of a number of biotechnology companies. He received his BA in Bacteriology from University of California Los Angeles and his PhD in Microbiology and Immunology from UCLA; he was a postdoctoral fellow at Rockefeller University.